Posted on November 13, 2019
Seeking the Win/Win/Win for Patients, Practices, Payers Read the original Nashville Medical News article HERE At this point in the move from fee-for-service to value-based reimbursement, everyone in healthcare is familiar with the triple aim of improving the patient care experience, improving the health of populations and reducing the per capita cost of care delivery. […]
Read MorePosted on November 5, 2019
Read original article HERE. Journal of American Medical Association Publishes Study Conducted at Tennessee Oncology OneOncology leaders — Aaron Lyss, MBA and Stephen Schleicher, MD, MBA — and leaders at Tuple Health, published an article in the Journal of American Medical Association (JAMA) Oncology examining the implications of the newly approved standard-of-care immunotherapies within the […]
Read MorePosted on October 28, 2019
Read full article HERE. AJMC®TV interviews let you catch up on what’s new and important about changes in healthcare, with insights from key decision makers—from the clinician, to the health plan leader, to the regulator. Stephen Schleicher, MD, MBA, Medical Oncologist, Tennessee Oncology What are your thoughts on the proposed Radiation Oncology Model and the fact that CMS wants […]
Read MorePosted on October 24, 2019
Read original article HERE. So far, 2019 has been one of the wackier years in the trajectory of the U.S. biosimilar space. It’s been the year in which the entire purpose of the biosimilar industry has been called into question. But it was also the year we started hearing how a number of organizations and […]
Read MorePosted on October 22, 2019
Read More